Cell Reprogramming Market by Technology (mRNA Reprogramming, Sendai virus-based Reprogramming, Episomal Reprogramming, Others), Application (Therapeutic, Research), End User (Biotechnology & Pharmaceutical Companies), and by Region - Global Forecast to 2022-2033

The cell reprogramming market size is estimated to be USD 376.2 million in 2022 and is expected to witness a CAGR of 8.54% during the forecast period 2023-2033. Developments in stem cell biology and regenerative medicine that can offer effective treatments and expanding applications of cell reprogramming in the healthcare field are factors contributing to the market growth. Furthermore, new market players entering the marketplace and growing investments made in this area by governments and private entities is expected to support the marker growth. However, is expected to hinder the growth.

Growing investments made in this area by governments and private entities is anticipated to propel the market. For instance, the U.K.-based Mogrify start-up raised an additional USD15.61 million for its Series A financing in May 2019. For the treatment of retinal degeneration, a form of blindness, Mogrify focuses in developing medicines and reprogramming human cells. Additionally, it is anticipated that the pharmaceutical sector would make extensive use of the iPSC technique to produce useful cell sources, such as iPSC-derived functional cells, to enable drug screening and toxicity evaluation, which will boost demand for cell reprogramming technology.

To fulfil the expanding demand and pursue unexplored market opportunities, new market players entering the marketplace with advanced technology. For instance, in January 2020, Astellas Pharma, Inc. and Allele Biotechnology & Pharmaceuticals, Inc., through its subsidiary Astellas Institute for Regenerative Medicine (AIRM), entered into a licensing deal to raise the focus on developing the company’s core competency in reprogramming somatic cells into iPSCs. To fully understand the unique potential of iPSC, Allele’s researchers and the cGMP team are committed to developing and validating cell assays for product quality control, genomic analysis workflows, closed-system technology for reprogramming, and machine learning.

Segmentation

By Technology

The market is categorized into mRNA reprogramming, sendai virus-based reprogramming, episomal reprogramming, and others. In 2022, the mRNA reprogramming segment accounted for the highest revenue share due to the fact that this technology is simple to use and provides a quick, safe, and efficient way to produce the highest-quality human iPS cells from somatic tissue. For instance, cell reprogramming with synthetic mRNA is a precise and safe way to produce human iPSCs, according to a February 2021 publication. Sendai virus-based reprogramming is expected to grow at substantially during the forecast period. It is frequently used in clinical trials of gene therapy and vaccine delivery as it promotes cell reprogramming at a constant rate and has technological advantages over alternative techniques.

By Application

The market is categorized into therapeutic and research. In the global market, the research segment accounted for the largest revenue share in 2022 owing to ongoing study of stem cells-assisted cell reprogramming. Governments and other private organisations are financing a significant amount of stem cell research projects, which is driving market players to build out niches in the global market by treating a variety of chronic diseases. For instance, 64% of Americans favour federal funding for studies using human embryonic stem cells to treat chronic diseases. Therefore, it is projected that research initiatives will support segment expansion.

By End User

The market is segmented into biotechnology & pharmaceutical companies, research & academic institutes, and hospitals & clinics. In 2022, the research & academic institutes segment accounted for the largest revenue share owing to rising demand for customized medications and the economically advantageous use of bio-drugs using this technology. The use of cell reprogramming in numerous academic and clinical applications, including disease modelling, drug toxicity/drug discovery studies, regenerative medicine, and others, is fuelling the market to expand. Rise in the number of strategic initiatives for research and method for improved products from cell reprogramming is also anticipated to propel the segment. For instance, The California Institute for Regenerative Medicine has pushed numerous research organisations to provide funding for the development of therapeutic applications and a clinical focus for cellular reprogramming.

Regional Markets

In 2022, North America region accounted for the highest revenue in the cell reprogramming market and is expected to maintain its dominance during the forecast period. This is attributed to the significant growth in iPSC technology and the accessibility of functional cells for pre-clinical drug testing. The region is growing as a result of high throughput drug toxicity analysis and growing iPSC platform knowledge. The increasing demand for novel treatment alternatives has spurred medical research activity in the United States. This enlarged study has favoured the need for cell reprogramming considering stem cell research is one of the key areas of focus. For instance, Ncardia announced the launch of a new company named Cellistic in April 2022 to support the growth of the iPSC reprogramming industry. Its focus on and expertise in differentiation, iPSC reprogramming, and other fields contribute to market expansion.

Asia Pacific is projected to be the market with the fastest growth owing to due to advancements in production and the effectiveness of the therapy landscape. As a result of the rising use of cell reprogramming technology, the sector is expanding. Additionally, the improvement of healthcare systems and the development of medical development frameworks in developing countries like Australia and India have positioned the Asia Pacific region for profitable growth during the forecast future.

Competitor Insights

Some of the key players operating in the cell reprogramming market are Alstem, Mogrify, Applied Biological Materials, Creative Bioarray, Axol Bioscience, DefiniGEN, Allele Biotechnology, Stemnovate, Lonza, Reprocell, Fujifilm Cellular Dynamics, and Thermo Fisher Scientific.

To increase their market position, major players are implementing numerous strategies into practise, such as partnerships through mergers and acquisitions, geographic growth, and strategic alliances.

  • For instance, Tidal Therapeutics was obtained by Sanofi in April 2021. The latest technological platform will also improve Sanofi’s research capabilities in immuno-oncology and inflammatory disorders, and it is projected to be broadly applicable to additional disease areas.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including technology, application, and end user from 2023 to 2033.

Report Scope:

Key Parameters Details
Market size in 2022
  • USD 376.2 Million
CAGR
  • 8.54%
Base Year
  • 2022
Forecast Period
  • 2023-2033
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • COVID-19 impact analysis
Segment Market Scope
  • Technology
  • Application
  • End user
Regional Market Scope
  • North America
    (U.S. and Canada)
  • Europe
    (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific
    (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America
    (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA
    (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 10 players
  • Other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Segmentation: Cell Reprogramming Market Report 2022 – 2033

Technology (Revenue, USD Million), 2022 – 2033

  • mRNA Reprogramming
  • Sendai virus-based Reprogramming
  • Episomal Reprogramming
  • Others

Application (Revenue, USD Million), 2022 – 2033

  • Therapeutic
  • Research

End user (Revenue, USD Million), 2022 – 2033

  • Biotechnology & Pharmaceutical Companies
  • Research & Academic Institutes
  • Hospitals & Clinics

By Region (Revenue, USD Million), 2022 – 2033

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Table of Contents: Cell Reprogramming Market 2022-2033

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
  1. Introduction: Cell Reprogramming
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. SWOT Analysis
  2. COVID-19 Impact Analysis: Cell Reprogramming Market
  3. Market Analysis by Technology
    1. mRNA Reprogramming
      1. mRNA Reprogramming Market Forecast, 2022-2033(USD Million)
    2. Sendai virus-based Reprogramming
      1. Sendai virus-based Reprogramming Market Forecast, 2022-2033(USD Million)
    3. Episomal Reprogramming
      1. Episomal Reprogramming Market Forecast, 2022-2033(USD Million)
    4. Others
      1. Others Market Forecast, 2022-2033(USD Million)
  1. Market Analysis by Application
    1. Therapeutic
      1. Therapeutic Market Forecast, 2022-2033(USD Million)
    2. Research
      1. Research Market Forecast, 2022-2033(USD Million)
  1. Market Analysis by End User
    1. Biotechnology & Pharmaceutical Companies
      1. Biotechnology & Pharmaceutical Companies Market Forecast, 2022-2033(USD Million)
    2. Research & Academic Institutes
      1. Research & Academic Institutes Market Forecast, 2022-2033(USD Million)
    3. Hospitals & Clinics
      1. Hospitals & Clinics Market Forecast, 2022-2033(USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends Analysis
  2. North America Cell Reprogramming Market
    1. North America Cell Reprogramming Market
      1. North America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Technology, 2022-2033(USD Million)
        2. Market Size and Forecast by Application, 2022-2033(USD Million)
        3. Market Size and Forecast by End User, 2022-2033(USD Million)
      2. S. Cell Reprogramming Market
        1. S. Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Technology, 2022-2033(USD Million)
          2. Market Size and Forecast by Application, 2022-2033(USD Million)
          3. Market Size and Forecast by End User, 2022-2033(USD Million)
        2. Canada Cell Reprogramming Market
          1. Canada Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Technology, 2022-2033(USD Million)
            2. Market Size and Forecast by Application, 2022-2033(USD Million)
            3. Market Size and Forecast by End User, 2022-2033(USD Million)
  1. Europe Cell Reprogramming Market
    1. Europe Cell Reprogramming Market
      1. Europe Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Technology, 2022-2033(USD Million)
        2. Market Size and Forecast by Application, 2022-2033(USD Million)
        3. Market Size and Forecast by End User, 2022-2033(USD Million)
      2. Germany Cell Reprogramming Market
        1. Germany Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Technology, 2022-2033(USD Million)
          2. Market Size and Forecast by Application, 2022-2033(USD Million)
          3. Market Size and Forecast by End User, 2022-2033(USD Million)
        2. UK Cell Reprogramming Market
          1. UK Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Technology, 2022-2033(USD Million)
            2. Market Size and Forecast by Application, 2022-2033(USD Million)
            3. Market Size and Forecast by End User, 2022-2033(USD Million)
          2. France Cell Reprogramming Market
            1. France Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Technology, 2022-2033(USD Million)
              2. Market Size and Forecast by Application, 2022-2033(USD Million)
              3. Market Size and Forecast by End User, 2022-2033(USD Million)
            2. Spain Cell Reprogramming Market
              1. Spain Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Technology, 2022-2033(USD Million)
                2. Market Size and Forecast by Application, 2022-2033(USD Million)
                3. Market Size and Forecast by End User, 2022-2033(USD Million)
              2. Italy Cell Reprogramming Market
                1. Italy Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Technology, 2022-2033(USD Million)
                  2. Market Size and Forecast by Application, 2022-2033(USD Million)
                  3. Market Size and Forecast by End User, 2022-2033(USD Million)
                2. Rest of Europe Cell Reprogramming Market
                  1. Rest of Europe Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Technology, 2022-2033(USD Million)
                    2. Market Size and Forecast by Application, 2022-2033(USD Million)
                    3. Market Size and Forecast by End User, 2022-2033(USD Million)
  1. Asia Pacific Cell Reprogramming Market
    1. Asia Pacific Cell Reprogramming Market
      1. Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Technology, 2022-2033(USD Million)
        2. Market Size and Forecast by Application, 2022-2033(USD Million)
        3. Market Size and Forecast by End User, 2022-2033(USD Million)
      2. Japan Cell Reprogramming Market
        1. Japan Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Technology, 2022-2033(USD Million)
          2. Market Size and Forecast by Application, 2022-2033(USD Million)
          3. Market Size and Forecast by End User, 2022-2033(USD Million)
        2. China Cell Reprogramming Market
          1. China Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Technology, 2022-2033(USD Million)
            2. Market Size and Forecast by Application, 2022-2033(USD Million)
            3. Market Size and Forecast by End User, 2022-2033(USD Million)
          2. India Cell Reprogramming Market
            1. India Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Technology, 2022-2033(USD Million)
              2. Market Size and Forecast by Application, 2022-2033(USD Million)
              3. Market Size and Forecast by End User, 2022-2033(USD Million)
            2. South Korea Cell Reprogramming Market
              1. South Korea Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Technology, 2022-2033(USD Million)
                2. Market Size and Forecast by Application, 2022-2033(USD Million)
                3. Market Size and Forecast by End User, 2022-2033(USD Million)
              2. Australia Cell Reprogramming Market
                1. Australia Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Technology, 2022-2033(USD Million)
                  2. Market Size and Forecast by Application, 2022-2033(USD Million)
                  3. Market Size and Forecast by End User, 2022-2033(USD Million)
                2. Rest of Asia Pacific Cell Reprogramming Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Technology, 2022-2033(USD Million)
                    2. Market Size and Forecast by Application, 2022-2033(USD Million)
                    3. Market Size and Forecast by End User, 2022-2033(USD Million)
  1. Latin America Cell Reprogramming Market
    1. Latin America Cell Reprogramming Market
      1. Latin America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Technology, 2022-2033(USD Million)
        2. Market Size and Forecast by Application, 2022-2033(USD Million)
        3. Market Size and Forecast by End User, 2022-2033(USD Million)
      2. Brazil Cell Reprogramming Market
        1. Brazil Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Technology, 2022-2033(USD Million)
          2. Market Size and Forecast by Application, 2022-2033(USD Million)
          3. Market Size and Forecast by End User, 2022-2033(USD Million)
        2. Mexico Cell Reprogramming Market
          1. Mexico Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Technology, 2022-2033(USD Million)
            2. Market Size and Forecast by Application, 2022-2033(USD Million)
            3. Market Size and Forecast by End User, 2022-2033(USD Million)
          2. Argentina Cell Reprogramming Market
            1. Argentina Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Technology, 2022-2033(USD Million)
              2. Market Size and Forecast by Application, 2022-2033(USD Million)
              3. Market Size and Forecast by End User, 2022-2033(USD Million)
            2. Rest of Latin America Cell Reprogramming Market
              1. Rest of Latin America Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Technology, 2022-2033(USD Million)
                2. Market Size and Forecast by Application, 2022-2033(USD Million)
                3. Market Size and Forecast by End User, 2022-2033(USD Million)
  1. MEA Cell Reprogramming Market
    1. MEA Cell Reprogramming Market
      1. MEA Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Technology, 2022-2033(USD Million)
        2. Market Size and Forecast by Application, 2022-2033(USD Million)
        3. Market Size and Forecast by End User, 2022-2033(USD Million)
      2. GCC Cell Reprogramming Market
        1. GCC Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Technology, 2022-2033(USD Million)
          2. Market Size and Forecast by Application, 2022-2033(USD Million)
          3. Market Size and Forecast by End User, 2022-2033(USD Million)
        2. South Africa Cell Reprogramming Market
          1. South Africa Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Technology, 2022-2033(USD Million)
            2. Market Size and Forecast by Application, 2022-2033(USD Million)
            3. Market Size and Forecast by End User, 2022-2033(USD Million)
          2. Rest of MEA Cell Reprogramming Market
            1. Rest of MEA Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Technology, 2022-2033(USD Million)
              2. Market Size and Forecast by Application, 2022-2033(USD Million)
              3. Market Size and Forecast by End User, 2022-2033(USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2022
    2. Major Recent Developments, 2019-2022
  2. Company Profiles
    1. Alstem
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    2. Mogrify
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    3. Applied Biological Materials
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    4. Creative Bioarray
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    5. Axol Bioscience
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    6. DefiniGEN
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    7. Allele Biotechnology
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    8. Stemnovate
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    9. Lonza
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    10. Reprocell
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    11. Fujifilm Cellular Dynamics
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    12. Thermo Fisher Scientific
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
  1. Conclusion
  2. Recommendations

Leave a comment

Your email address will not be published. Required fields are marked *

Select License Type

5 reasons to choose Quintana Research Reports

Our top-quality, real-time, accurate, and data-driven research aims at empowering the clients with actionable insights.

We deliver timely data-driven insights to help clients make informed decisions and achieve growth and success.

Our team of experts is available 24*7 to offer incisive analysis of the market for clients.

We offer comprehensive and bespoke marketing research as per clients’ requirements.

Our cost-effective and rapid research helps clients gain competitive intelligence, and uncover potential opportunities & threats.